This problem considers bioreactors and how their connection to bioprocesses and biosystems lead to much larger challenges as opposed to working with non-biological and purely chemical systems. The image below describes challenges associated with challenges in bioreactors.
The problems here may seem to be frustrating for biochemists and biochemical engineers. However, quality control and regulatory constrains prioritize the public health as there is a lot of risk involved with creating a bioproduct for public use, such as a pharmaceutical. Mistakes in the production of bioproducts can lead to drastic consequences for the public. A good example of drastic consequences resulting from mistakes in bioproduct production is the uncontrollable outbreak of COVID-19.